Enzyme Catalysis

• Currently, Medicilon has successfully established dozens of major biological enzyme libraries, including ketoreductase, ester hydrolase, imine reductase, nitroreductase, cyclooxygenase, and amide hydrolase. These libraries provide suitable biocatalytic solutions for various chemical transformations. These integrated enzymatic services reduce costs, shorten timeframes, and improve quality. With the implementation of numerous projects, Medicilon's enzyme library continues to be optimized and expanded. Additionally, Medicilon will conduct research on immobilized enzymes and coenzymes.

Medicilon’s R&D capabilities in the field of synthetic biology

• With the continuous advancement of synthetic biology technology, an increasing number of enzymes with specific catalytic functions are being used as biocatalysts to achieve reactions that are challenging with chemical catalysts. These enzymes also serve as catalytic components to construct functional modules in synthetic biology. Medicilon has already established a strong presence in this field. Through the assembly of different enzyme components, Medicilon has achieved breakthroughs in designing synthetic routes for numerous target molecules. We offer a variety of services including:
  Molecule and Strain ConstructionStrain Delection and DomesticationEnzyme Co-ExpressionMulti-Enzyme CatalysisBiocatalysisProtein ModificationFermentation MetabolismProtein PurificationFermentation OptimizationEnzyme Immobilization
  In the future, Medicilon, as a one-stop biopharmaceutical preclinical R&D service platform, will continue to explore and apply more innovative green chemical technologies. Our aim is to achieve more environmentally friendly, safe, efficient, and economical process development and production, creating innovative products for clients around the globe.